Literature DB >> 18935923

Moral accountability and debriefing.

Bryan Benham1.   

Abstract

What is the ethical significance of debriefing in deceptive research? The standard view of debriefing is that it serves to disclose the deception to the participant and is a means of evaluating and mitigating potential harms that may have resulted from involvement in the research. However, as the article by Miller, Gluck, and Wendler in this issue of the Kennedy Institute of Ethics Journal points out, there has been little systematic attention to the ethics of debriefing, particularly with regard to the role of debriefing in addressing the prima facie moral wrong of deception itself. They argue that in addition to mitigating the harms of deception, debriefing should include an apology to participants for being deceived. In the current paper, I argue that an apology is not morally obligatory in most research contexts. Debriefing should be considered an opportunity to further define the researcher-participant relationship without the need to be remorseful about the research practice.

Entities:  

Mesh:

Year:  2008        PMID: 18935923     DOI: 10.1353/ken.0.0197

Source DB:  PubMed          Journal:  Kennedy Inst Ethics J        ISSN: 1054-6863


  3 in total

1.  Randomized evaluation of trial acceptability by INcentive (RETAIN): Study protocol for two embedded randomized controlled trials.

Authors:  Dustin C Krutsinger; Jacqueline McMahon; Alisa J Stephens-Shields; Brian Bayes; Steven Brooks; Brian L Hitsman; Su Fen Lubitz; Celine Reyes; Robert A Schnoll; S Ryan Greysen; Ashley Mercede; Mitesh S Patel; Catherine Reale; Fran Barg; Jason Karlawish; Daniel Polsky; Kevin G Volpp; Scott D Halpern
Journal:  Contemp Clin Trials       Date:  2018-11-08       Impact factor: 2.226

2.  Journalists, district attorneys and researchers: why IRBs should get in the middle.

Authors:  Anna H Chodos; Sei J Lee
Journal:  BMC Med Ethics       Date:  2015-03-29       Impact factor: 2.652

3.  Attitudes and Perceptions Toward Authorized Deception: A Pilot Comparison of Healthy Controls and Fibromyalgia Patients.

Authors:  Susan J Goo; Eleni Frangos; Emily A Richards; Marta Ceko; Brenda L Justement; Patrick Korb; Brian T Walitt; Luana Colloca; M Catherine Bushnell
Journal:  Pain Med       Date:  2020-04-01       Impact factor: 3.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.